AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

PHG · NYSE · Medical - Devices

Philips (ADR) (PHG)

Builds clinical imaging, connected-care systems, respiratory equipment, and personal-health devices.

$24.50

vs last close−0.47 (−1.90%)

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	5,095	5,769	4,716	5,085	4,988	5,748	4,669	4,944	4,903	5,809	4,450	4,969
Cost of revenue	2,892	3,719	2,647	2,818	2,702	3,511	2,562	2,652	2,726	3,201	2,439	2,519
Gross profit	2,203	2,050	2,068	2,267	2,286	2,237	2,107	2,292	2,177	2,607	2,013	2,450
	1,948	2,023	3,007	1,337	1,902	2,010	1,932	1,836	1,801	1,992	1,737	1,755
Research & development	507	870	477	483	493	538	521	458	472	487	449	552
	1,440	1,553	1,404	1,464	1,397	1,510	1,422	1,412	1,342	1,487	1,349	1,375
Selling & marketing	1,270	1,390	1,249	1,284	1,225	1,354	1,239	1,235	1,167	1,307	1,148	1,200
General & administrative	171	163	155	180	172	156	183	177	175	180	202	175
Other expenses	0	−400	1,126	−611	11	−38	−11	−34	−14	18	−62	−172
Operating income	255	27	−939	930	384	227	175	456	376	615	275	695
	−108	−134	−80	−182	−103	−95	−56	−72	−63	−84	−58	−73
Interest income	17	0	27	23	39	6	38	26	24	43	40	38
Interest expense	104	17	107	100	119	65	93	91	89	123	95	108
Other non-operating income	3	−606	−1	613	−16	1	−36	−19	−2	−39	−36	−35
Income before tax	147	−107	−1,019	748	281	132	120	384	313	531	217	622
Income tax expense	36	−150	120	393	74	512	31	108	99	83	50	182
Net income from continuing operations	111	43	−1,138	354	207	−379	89	276	214	448	166	440
Discontinued operations	−8	−1	1	161	0	0	−7	−2	−1	5	0	0
Other adjustments	0	0	−1	1	−1	−1	0	0	0	0	0	0
Net income	100	44	−1,138	514	206	−382	87	274	210	450	172	438
EPS, basic	$0.11	$0.05	−$1.24	$0.55	$0.23	−$0.41	$0.09	$0.28	$0.22	$0.47	$0.18	$0.46
EPS, diluted	$0.11	$0.05	−$1.22	$0.55	$0.23	−$0.41	$0.09	$0.28	$0.22	$0.47	$0.18	$0.46
Weighted average shares, basic	934	935	913	939	902	928	925	946	964	963	952	956
Weighted average shares, diluted	948	935	937	942	913	929	938	957	964	966	969	969
EBITDA	252	836	−736	680	400	622	526	778	724	972	613	1,165
Depreciation & amortization	0	202	202	364	0	396	315	303	345	318	302	434
EBIT	252	634	−938	317	400	226	212	475	378	654	311	730